Annual SGA
$108.15 M
+$60.02 M+124.70%
December 31, 2023
Summary
- As of February 7, 2025, MDGL annual SGA is $108.15 million, with the most recent change of +$60.02 million (+124.70%) on December 31, 2023.
- During the last 3 years, MDGL annual SGA has risen by +$86.28 million (+394.63%).
- MDGL annual SGA is now at all-time high.
Performance
MDGL SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$107.58 M
+$2.14 M+2.03%
September 30, 2024
Summary
- As of February 7, 2025, MDGL quarterly SGA is $107.58 million, with the most recent change of +$2.14 million (+2.03%) on September 30, 2024.
- Over the past year, MDGL quarterly SGA has increased by +$2.14 million (+2.03%).
- MDGL quarterly SGA is now at all-time high.
Performance
MDGL Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$6.20 B
-$518.67 M-9.13%
September 30, 2024
Summary
- As of February 7, 2025, MDGL TTM SGA is -$6.20 billion, with the most recent change of -$518.67 million (-9.13%) on September 30, 2024.
- Over the past year, MDGL TTM SGA has dropped by -$6.46 billion (-2480.75%).
- MDGL TTM SGA is now -4732.08% below its all-time high of -$128.28 million.
Performance
MDGL TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
MDGL Selling, General & Administrative Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +124.7% | +2.0% | -2480.8% |
3 y3 years | +394.6% | +2.0% | -2480.8% |
5 y5 years | +607.2% | +2.0% | -2480.8% |
MDGL Selling, General & Administrative Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +189.8% | at high | +1014.0% | -170.9% | at low |
5 y | 5-year | at high | +394.6% | at high | +2236.3% | -729.7% | at low |
alltime | all time | at high | >+9999.0% | at high | >+9999.0% | -4732.1% | at low |
Madrigal Pharmaceuticals Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $107.58 M(+2.0%) | $340.37 M(+30.7%) |
Jun 2024 | - | $105.45 M(+30.5%) | $260.37 M(+50.7%) |
Mar 2024 | - | $80.80 M(+73.6%) | $172.76 M(+59.8%) |
Dec 2023 | $108.15 M(+124.7%) | $46.54 M(+68.7%) | $108.15 M(+42.0%) |
Sep 2023 | - | $27.58 M(+54.6%) | $76.17 M(+25.4%) |
Jun 2023 | - | $17.84 M(+10.3%) | $60.73 M(+11.1%) |
Mar 2023 | - | $16.18 M(+11.2%) | $54.65 M(+13.6%) |
Dec 2022 | $48.13 M(+29.0%) | $14.56 M(+19.9%) | $48.13 M(+6.3%) |
Sep 2022 | - | $12.14 M(+3.1%) | $45.28 M(+9.3%) |
Jun 2022 | - | $11.77 M(+21.9%) | $41.43 M(+4.2%) |
Mar 2022 | - | $9.66 M(-17.5%) | $39.77 M(+6.6%) |
Dec 2021 | $37.32 M(+70.7%) | $11.71 M(+41.3%) | $37.32 M(+17.6%) |
Sep 2021 | - | $8.29 M(-18.0%) | $31.73 M(+9.7%) |
Jun 2021 | - | $10.11 M(+40.2%) | $28.94 M(+18.3%) |
Mar 2021 | - | $7.21 M(+17.7%) | $24.47 M(+11.9%) |
Dec 2020 | $21.86 M(-3.5%) | $6.13 M(+11.5%) | $21.86 M(+5.2%) |
Sep 2020 | - | $5.49 M(-2.6%) | $20.78 M(+3.7%) |
Jun 2020 | - | $5.64 M(+22.5%) | $20.04 M(-6.8%) |
Mar 2020 | - | $4.61 M(-8.7%) | $21.51 M(-5.0%) |
Dec 2019 | $22.65 M(+48.1%) | $5.04 M(+6.2%) | $22.65 M(-2.3%) |
Sep 2019 | - | $4.75 M(-33.2%) | $23.19 M(-1.6%) |
Jun 2019 | - | $7.11 M(+23.7%) | $23.56 M(+22.9%) |
Mar 2019 | - | $5.75 M(+2.9%) | $19.17 M(+25.3%) |
Dec 2018 | $15.29 M(+99.3%) | $5.58 M(+9.0%) | $15.29 M(+26.3%) |
Sep 2018 | - | $5.12 M(+88.5%) | $12.11 M(+35.4%) |
Jun 2018 | - | $2.72 M(+45.2%) | $8.94 M(+13.9%) |
Mar 2018 | - | $1.87 M(-22.0%) | $7.85 M(+2.3%) |
Dec 2017 | $7.67 M(-17.4%) | $2.40 M(+22.7%) | $7.67 M(+2.2%) |
Sep 2017 | - | $1.96 M(+20.5%) | $7.50 M(-36.6%) |
Jun 2017 | - | $1.62 M(-4.2%) | $11.84 M(+10.0%) |
Mar 2017 | - | $1.70 M(-24.1%) | $10.76 M(+15.9%) |
Dec 2016 | $9.29 M(+1052.9%) | $2.23 M(-64.5%) | $9.29 M(+29.0%) |
Sep 2016 | - | $6.29 M(+1040.7%) | $7.20 M(+545.7%) |
Jun 2016 | - | $551.00 K(+148.2%) | $1.12 M(-69.8%) |
Mar 2016 | - | $222.00 K(+53.0%) | $3.69 M(-51.6%) |
Dec 2015 | $805.80 K(-94.9%) | $145.10 K(-26.5%) | $7.62 M(-35.0%) |
Sep 2015 | - | $197.40 K(-93.7%) | $11.72 M(-20.6%) |
Jun 2015 | - | $3.13 M(-24.7%) | $14.76 M(+1.3%) |
Mar 2015 | - | $4.15 M(-2.1%) | $14.57 M(-7.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2014 | $15.75 M(+0.3%) | $4.24 M(+30.9%) | $15.75 M(+5.2%) |
Sep 2014 | - | $3.24 M(+10.2%) | $14.97 M(-5.8%) |
Jun 2014 | - | $2.94 M(-44.8%) | $15.90 M(-7.3%) |
Mar 2014 | - | $5.32 M(+53.7%) | $17.14 M(+9.2%) |
Dec 2013 | $15.70 M(+34.5%) | $3.46 M(-17.0%) | $15.70 M(+0.7%) |
Sep 2013 | - | $4.17 M(-0.4%) | $15.59 M(+9.7%) |
Jun 2013 | - | $4.19 M(+8.0%) | $14.21 M(+10.1%) |
Mar 2013 | - | $3.88 M(+15.7%) | $12.91 M(+10.6%) |
Dec 2012 | $11.68 M(+1.1%) | $3.35 M(+19.9%) | $11.68 M(+4.9%) |
Sep 2012 | - | $2.80 M(-3.0%) | $11.13 M(-2.9%) |
Jun 2012 | - | $2.88 M(+8.9%) | $11.46 M(-0.6%) |
Mar 2012 | - | $2.65 M(-5.6%) | $11.53 M(-0.2%) |
Dec 2011 | $11.55 M(+0.9%) | $2.80 M(-10.5%) | $11.55 M(-2.1%) |
Sep 2011 | - | $3.13 M(+6.3%) | $11.81 M(+4.8%) |
Jun 2011 | - | $2.95 M(+10.2%) | $11.27 M(+2.1%) |
Mar 2011 | - | $2.67 M(-12.5%) | $11.04 M(-3.6%) |
Dec 2010 | $11.45 M(-9.5%) | $3.06 M(+17.9%) | $11.45 M(+5.8%) |
Sep 2010 | - | $2.59 M(-4.6%) | $10.82 M(-4.9%) |
Jun 2010 | - | $2.72 M(-12.0%) | $11.38 M(-2.5%) |
Mar 2010 | - | $3.09 M(+27.2%) | $11.67 M(-7.8%) |
Dec 2009 | $12.65 M(-14.2%) | $2.43 M(-22.9%) | $12.65 M(-7.6%) |
Sep 2009 | - | $3.15 M(+4.8%) | $13.69 M(-3.6%) |
Jun 2009 | - | $3.00 M(-26.2%) | $14.21 M(-6.4%) |
Mar 2009 | - | $4.07 M(+17.3%) | $15.18 M(+3.0%) |
Dec 2008 | $14.74 M(-1.3%) | $3.47 M(-5.3%) | $14.74 M(-1.9%) |
Sep 2008 | - | $3.67 M(-7.8%) | $15.02 M(-1.2%) |
Jun 2008 | - | $3.97 M(+9.4%) | $15.21 M(+0.8%) |
Mar 2008 | - | $3.63 M(-3.2%) | $15.09 M(+1.1%) |
Dec 2007 | $14.93 M(+72.7%) | $3.75 M(-2.6%) | $14.93 M(+9.0%) |
Sep 2007 | - | $3.85 M(-0.0%) | $13.69 M(+15.5%) |
Jun 2007 | - | $3.85 M(+11.1%) | $11.86 M(+48.2%) |
Mar 2007 | - | $3.47 M(+37.7%) | $8.00 M(+76.5%) |
Dec 2006 | $8.65 M(-23.3%) | $2.52 M(+24.9%) | $4.53 M(+124.9%) |
Sep 2006 | - | $2.02 M(-11.6%) | $2.02 M(-11.6%) |
Dec 2005 | $11.28 M(+52.8%) | - | - |
Mar 2005 | - | $2.28 M | $2.28 M |
Dec 2004 | $7.38 M(+40.3%) | - | - |
Dec 2003 | $5.26 M(+4142.7%) | - | - |
Dec 2001 | $124.00 K | - | - |
FAQ
- What is Madrigal Pharmaceuticals annual SGA?
- What is the all time high annual SGA for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual SGA year-on-year change?
- What is Madrigal Pharmaceuticals quarterly SGA?
- What is the all time high quarterly SGA for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly SGA year-on-year change?
- What is Madrigal Pharmaceuticals TTM SGA?
- What is the all time high TTM SGA for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals TTM SGA year-on-year change?
What is Madrigal Pharmaceuticals annual SGA?
The current annual SGA of MDGL is $108.15 M
What is the all time high annual SGA for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual SGA is $108.15 M
What is Madrigal Pharmaceuticals annual SGA year-on-year change?
Over the past year, MDGL annual SGA has changed by +$60.02 M (+124.70%)
What is Madrigal Pharmaceuticals quarterly SGA?
The current quarterly SGA of MDGL is $107.58 M
What is the all time high quarterly SGA for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly SGA is $107.58 M
What is Madrigal Pharmaceuticals quarterly SGA year-on-year change?
Over the past year, MDGL quarterly SGA has changed by +$2.14 M (+2.03%)
What is Madrigal Pharmaceuticals TTM SGA?
The current TTM SGA of MDGL is -$6.20 B
What is the all time high TTM SGA for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high TTM SGA is -$128.28 M
What is Madrigal Pharmaceuticals TTM SGA year-on-year change?
Over the past year, MDGL TTM SGA has changed by -$6.46 B (-2480.75%)